Background-Since smoking has a profound impact on socioeconomic disparities in illness and death, it is crucial that vulnerable populations of smokers be targeted with treatment. The US Public Health Service recommends that all patients be asked about their smoking at every visit, and that smokers be given brief advice to quit and referred to treatment.
Setting/participants-Ten safety-net clinics in Houston, TX.
Intervention-Clinics were randomized to AAC (n=5; intervention) or AAR (n=5; control). Licensed Vocational Nurses (LVNs) were trained to assess and record the smoking status of all patients at all visits in the electronic health record (EHR). Smokers were given brief advice to quit. In AAC, the names and phone numbers of smokers who agreed to be connected were sent electronically to the Texas Quitline daily, and patients were proactively called within 48 hours. In AAR, smokers were offered a Quitline referral card and encouraged to call on their own. Data were collected between June 2010 and March 2012 and analyzed in 2012.
Main Outcome Measure-The primary outcome -impact -was defined as the proportion of identified smokers that enrolled in treatment.
Results-The impact (proportion of identified smokers who enrolled in treatment) of AAC (14.7%) was significantly greater than the impact of AAR (0.5%), t (4) = 14.61, p = 0.0001, OR = 32.10 (95% CI 16.60-62.06).
Conclusions-AAC has tremendous potential to reduce tobacco-related health disparities.
BACKGROUND
Smoking is becoming increasingly concentrated among individuals with the lowest levels of education, income, and occupational status, [1] [2] [3] [4] [5] [6] and has a profound impact on socioeconomic disparities in the United States. [7] [8] [9] Therefore, it is crucial that vulnerable populations of smokers be targeted with evidence-based cessation treatment. 10 Because evidence-based treatments delivered by quitlines are underutilized, 16 formalizing partnerships with healthcare systems has been identified as a critical strategy for enhancing their reach and overall impact. 16 Despite 5 A's (i.e., Ask, Advise, Assess, Assist, Arrange) and "Ask Advise Refer (AAR)" initiatives, 121117181920 treatments have not been well integrated within healthcare systems. 10, 16, [21] [22] [23] [24] Thus, there is a critical need to address treatment barriers. We recently evaluated the efficacy of a new, electronic health record (EHR)-based approach to connect smokers in healthcare settings with treatment called "Ask Advise Connect" (AAC). Results of our initial trial, conducted in a private healthcare system, indicated that AAC (vs. AAR) was associated with a 13-fold increase in treatment enrollment. 25 The current study utilized similar methodology and was intended to replicate the findings in a safety-net healthcare system.
METHODS

Study Design
A pair-matched group randomized design in 10 Harris Health System community health clinics was utilized. The clinics serve nearly 200,000 unique adult patients per year, 90% are members of racial/ethnic minority groups, and nearly half have incomes below poverty. Five clinics were randomized to AAC (intervention) and five were randomized to AAR (control condition). The dissemination period was 18 months. Data were collected between June 2010 and March 2012 and analyzed in 2012. The protocol was published in 2010. 26 
Participants
Participants were current smokers ≥18 who were seen the clinics. There was no racial or gender bias in participant selection. IRB approval was obtained from MD Anderson Cancer Center, Harris Health System, and the Texas Department of State Health Services.
Randomization
Randomization occurred at the clinic level. Clinics were initially paired by the investigators based on patient volume, average age, gender, race/ethnicity, and percent below poverty. One clinic within each pair was then randomly assigned to one of the two arms.
Procedures
In AAC and AAR, Licensed Vocational Nurses (LVNs) were trained to assess and record the smoking status of all patients at all visits in the EHR when vital signs were collected. They were also trained to provide smokers with brief advice to quit consistent with the Guideline. 11 A 30-minute training session on how to assess smoking status, deliver brief advice to quit, and connect (AAC) or refer (AAR) patients to the Quitline was held at the beginning of the trial. In AAC, LVNs directly connected patients with the Quitline through clicking an automated link in the EHR that sent smokers' names and phone numbers to the research team, who then sent the information to the Quitline within 24 hours. Patients were contacted by the Quitline within 48 hours. In AAR, LVNs gave smokers willing to accept assistance a Quitline referral card.
Smoking status and willingness to be connected (in AAC) or referred (in AAR) were recorded using the EHR. An Excel data file was automatically and securely sent to the research team daily, and forwarded to the Quitline daily. Treatment enrollment was tracked and recorded by the Quitline. Data were maintained in an Access database.
Outcome Measures: Reach, Efficacy and Impact
Reach, efficacy, and impact were evaluated using the RE-AIM framework. 27 Reach = number of smokers that talked with Quitline / total number of identified smokers. Efficacy = number of smokers that enrolled in Quitline treatment / total number of identified smokers that talked with Quitline. Impact = Reach × Efficacy.
Data Analysis
Proportions for Reach, Efficacy, and Impact were calculated and the magnitude and significance of differences between AAC and AAR were evaluated using Donner and Donald's weighted empirical logistic transformation approach. This approach accounts for nesting of individuals within clinics and induced intraclass correlation and was used because the data were generated using a pair-matched-two-treatment arm group randomized trial. 28 This method accounts for the probability of imbalance between treatment groups on participant characteristics, and provides estimated odds ratios (ORs) for assessing the significance of the intervention effects over all strata.
RESULTS
Smoking prevalence was 16.0% (17,959 / 112,112) , and higher in AAC (7, 
Reach
In AAC, 7,237 smokers were identified, and in AAR, 10,722 smokers were identified. In AAC, 23.6% of identified smokers talked with the Quitline (1,707 / 7,237) and in AAR, 0.5% of identified smokers talked with the Quitline (56 / 10,722). The empirical logistic transformation approach indicated that the Reach was significantly greater in AAC (vs. AAR), t(4)=18.60, p=.00005. 28 The overall estimated odds ratio (OR) and 95% CI for assessing the intervention on Reach over all strata was equal to 56.19 (95% CI 30.79-102.53).
Efficacy
Of the 1,707 smokers that talked with the Quitline in AAC, 1,060 enrolled in treatment (62.1% enrollment rate). Of the 56 smokers in AAR that talked with the Quitline, 53 enrolled in treatment (94.6% enrollment rate). The unconditional test for equivalence of two binomial proportions was used to compare treatment enrollment in AAR versus AAC. The Efficacy of AAR (vs. AAC) was significantly greater (standardized Z statistic = 4.97, p=3.4×10 −7 .).
Impact
Impact was significantly greater in AAC (23.6% × 62.1% = 14.7%) than in AAR (0.5% × 94.6% = 0.5%), t (4) = 14.61, p = 0.0001. 28 The overall estimated OR for assessing the effect of the intervention on impact over all strata was equal to 32.10 (95% CI 16.60-62.06).
CONCLUSIONS
Directly connecting low-income, racially/ethnically diverse smokers to the Quitline via an automated link in the EHR resulted in a nearly 30-fold increase in treatment enrollment compared to providing referral cards and asking smokers to call on their own. This treatment enrollment rate is larger than in any study previously reported. Importantly, AAC yielded a larger effect size in a safety-net healthcare system than a private healthcare system (30-fold vs. 13-fold increase in treatment enrollment). 25 Recent healthcare reform legislation has created an environment in which programs such as AAC could be integrated and sustained within healthcare settings. [29] [30] [31] A strength is that AAC was evaluated in a setting representative of real-world healthcare systems that serve smokers disproportionately burdened by tobacco. Additionally, AAC could be implemented broadly in other healthcare settings. A limitation is that smoking outcome data were not collected, and smokers who called the Quitline may have been more motivated to quit. Another limitation is the absence of a fidelity check on LVNs. That smoking prevalence (16%) was lower than would be expected in this population, and differed between AAC (17.9%) and AAR (15.0%) clinics, suggests that all patients were not for smoking status, and that AAC (vs. AAR) clinics may have more systematically screened and documented smoking status. Finally, the national infrastructure for supporting quitlines would need to be expanded to be sufficient to support widespread adoption of AAC.
In summary, widespread adoption of AAC could reduce tobacco-related morbidity and mortality, and the large effect obtained in a safety-net healthcare system supports the potential of AAC to reduce tobacco-related health disparities. Reach, Efficacy, and Impact for AAC and AAR Notes: Reach = proportion of smokers identified who talked with Quitline; Efficacy = proportion of smokers who talked with Quitlline that enrolled in treatment; Impact = Reach × Efficacy 
